Literature DB >> 21033181

Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999.

.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging community-acquired pathogen among patients without established risk factors for MRSA infection (e.g., recent hospitalization, recent surgery, residence in a long-term-care facility [LTCF], or injecting-drug use [IDU]) (1). Since 1996, the Minnesota Department of Health (MDH) and the Indian Health Service (IHS) have investigated cases of community-acquired MRSA infection in patients without established risk factors. This report describes four fatal cases among children with community-acquired MRSA; the MRSA strains isolated from these patients appear to be different from typical nosocomial MRSA strains in antimicrobial susceptibility patterns and pulsed-field gel electrophoresis (PFGE) characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 21033181

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  185 in total

1.  Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains.

Authors:  Xiao Xue Ma; Teruyo Ito; Chuntima Tiensasitorn; Mantana Jamklang; Piriyaporn Chongtrakool; Susan Boyle-Vavra; Robert S Daum; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.

Authors:  E B Hume; J J Dajcs; J M Moreau; R J O'Callaghan
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

4.  Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors.

Authors:  Jose M. Eguia; Henry F. Chambers
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

Review 5.  Antimicrobial resistance: the example of Staphylococcus aureus.

Authors:  Franklin D Lowy
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

6.  Controlling methicillin resistant Staphylococcus aureus.

Authors:  Georgia Duckworth
Journal:  BMJ       Date:  2003-11-22

7.  Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

Authors:  P D Fey; B Saïd-Salim; M E Rupp; S H Hinrichs; D J Boxrud; C C Davis; B N Kreiswirth; P M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

8.  Molecular characteristics of nosocomial and Native American community-associated methicillin-resistant Staphylococcus aureus clones from rural Wisconsin.

Authors:  Sanjay K Shukla; Mary E Stemper; Srinivas V Ramaswamy; Jennifer M Conradt; Robert Reich; Edward A Graviss; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

9.  In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.

Authors:  Samuel A Shelburne; Daniel M Musher; Kristina Hulten; Heather Ceasar; Michael Y Lu; Imran Bhaila; Richard J Hamill
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections.

Authors:  Ronald N Jones; Angela M Nilius; Bolanle K Akinlade; Lalitagauri M Deshpande; Gerard F Notario
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.